The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy
The aim of the present study was to investigate the association of the pre-treatment C-reactive protein (CRP) plasma level with survival outcomes in a cohort of 423 consecutive patients with locally advanced rectal cancer treated with neo-adjuvant radiochemotherapy followed by surgical resection. To...
Main Authors: | Richard Partl, Katarzyna Lukasiak, Eva-Maria Thurner, Wilfried Renner, Heidi Stranzl-Lawatsch, Tanja Langsenlehner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/10/780 |
Similar Items
-
Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer
by: Benedikt eEngels, et al.
Published: (2012-05-01) -
Prognostic significance of tumor regression in locally advanced rectal cancer after preoperative radiochemotherapy
by: Omejc Mirko, et al.
Published: (2017-12-01) -
Side Effects and Disease-Free Survival with Capecitabine Compared to 5FU for Concurrent Radiochemotherapy of Rectal Cancer: A 5-year Review
by: Peiman Haddad, et al.
Published: (2014-01-01) -
Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
by: Leif Hendrik Dröge, et al.
Published: (2021-03-01) -
Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using <sup>18</sup> F-FDG PET-CT imaging. A prospective clinical study
by: Goldberg Natalia, et al.
Published: (2012-08-01)